Product Code: GVR-4-68040-801-6
AI In U.S. Animal Health Market Summary
The AI in U.S. animal health market size was estimated at USD 514.83 million in 2024 and is projected to reach USD 2,518.84 million by 2033, growing at a CAGR of 19.94% from 2025 to 2033. The market is growing rapidly due to increasing demand for faster, more accurate diagnostics, rising prevalence of pet diseases, increasing pet ownership, and spending on advanced veterinary care.
In addition, artificial intelligence (AI) integration in diagnostic imaging, predictive analytics, and remote monitoring enhances clinical efficiency and early disease detection. The Artificial Intelligence in U.S. animal health market is rapidly evolving, driven by the growing demand for faster, more accurate diagnostics and the increasing use of digital tools in veterinary practices. AI technologies are revolutionizing veterinary care by automating image analysis, streamlining diagnostics, and enhancing clinical decision-making. Companies such as Zoetis are leading innovation with AI-powered solutions such as Vetscan Imagyst, which provides automated cytology and fecal analysis, enabling veterinarians to diagnose conditions within minutes. Similarly, IDEXX Laboratories and Mars Petcare's ANTECH are integrating AI into imaging and pathology platforms to enhance diagnostic precision and operational efficiency across veterinary networks.
Beyond diagnostics, AI is expanding into preventive care, disease prediction, and personalized treatment planning. Wearable devices and remote monitoring systems, such as those developed by Whistle Health and PetPace, use AI algorithms to track vital signs, detect behavioral changes, and alert owners or veterinarians to potential health issues in real time. These innovations address the nationwide shortage of veterinary professionals by improving workflow automation and enabling data-driven care.
Strategic partnerships and technological convergence further support the market's growth. For instance, Covetrus Pulse integrates seamlessly with Zoetis Diagnostics, linking AI-powered tools such as Imagyst to cloud-based management systems for faster data sharing, billing accuracy, and improved patient outcomes. With continued advances in machine learning, connectivity, and cloud infrastructure, AI is poised to redefine animal healthcare delivery in the U.S., making diagnostics more accessible, efficient, and proactive across both companion and production animal sectors.
AI In U.S. Animal Health Market Report Segmentation
This report forecasts revenue growth at U.S. and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the AI in U.S. animal health market report based on solution, animal type, and application:
- Solution Outlook (Revenue, USD Million, 2021 - 2033)
- Hardware
- Software & Services
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Diagnostics
- Identification, Tracking, and Monitoring
- Others
- Animal Type Outlook (Revenue, USD Million, 2021 - 2033)
- Companion Animals
- Production Animals
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Solution
- 1.2.2. Animal Type
- 1.2.3. Application
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
- 1.5. Information/Data Analysis
- 1.5.1. Data Analysis Models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Model 1: Commodity Flow Analysis
- 1.7.2. Model 2: Bottom-Up Analysis
- 1.7.3. Model 3 Volume-Pricing Analysis
- 1.8. List of Secondary Sources
- 1.9. List Of Abbreviations
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Artificial Intelligence (AI) in U.S. Animal Health Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing demand for improving animal health outcomes
- 3.2.1.2. Technological advancements
- 3.2.1.3. Increasing adoption of AI in remote monitoring and telemedicine
- 3.2.1.4. Growing applications of AI in veterinary healthcare
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Limited data availability and quality
- 3.2.2.2. Ethical and legal considerations
- 3.2.2.3. Data safety and privacy concerns
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.3. Artificial Intelligence (AI) in U.S. Animal Health Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological landscape
- 3.3.3. Estimated Animal Population, by key species & key countries, 2024
- 3.3.4. Technology Landscape
- 3.3.5. Product Pricing Analysis
- 3.3.6. User Perspective Analysis
Chapter 4. Artificial Intelligence (AI) in U.S. Animal Health Market: Solutions Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Artificial Intelligence (AI) in U.S. Animal Health Market: Solutions Movement Analysis & Market Share, 2024 & 2033
- 4.3. Hardware
- 4.3.1. Hardware Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4. Software & Services
- 4.4.1. Software & Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Artificial Intelligence (AI) in U.S. Animal Health Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Artificial Intelligence (AI) in U.S. Animal Health Market: Application Movement Analysis & Market Share, 2024 & 2033
- 5.3. Diagnostics
- 5.3.1. Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.4. Identification, Tracking, and Monitoring
- 5.4.1. Identification, Tracking, and Monitoring Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Others
- 5.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Artificial Intelligence (AI) in U.S. Animal Health Market: Animal Type Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Artificial Intelligence (AI) in U.S. Animal Health Market: Animal Type Movement Analysis & Market Share, 2024 & 2033
- 6.3. Companion Animals
- 6.3.1. Companion Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4. Production Animals
- 6.4.1. Production Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Market Participant Categorization
- 7.1.1. Market Leaders
- 7.1.2. Emerging Players
- 7.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
- 7.3. Company Profiles
- 7.3.1. Zoetis Services LLC
- 7.3.1.1. Company Overview
- 7.3.1.2. Financial Performance
- 7.3.1.3. Solutions Benchmarking
- 7.3.1.4. Strategic Initiatives
- 7.3.2. Merck & Co., Inc.
- 7.3.2.1. Company Overview
- 7.3.2.2. Financial Performance
- 7.3.2.3. Solutions Benchmarking
- 7.3.2.4. Strategic Initiatives
- 7.3.3. Heska Corporation
- 7.3.3.1. Company Overview
- 7.3.3.2. Financial Performance
- 7.3.3.3. Solutions Benchmarking
- 7.3.3.4. Strategic Initiatives
- 7.3.4. SignalPET
- 7.3.4.1. Company Overview
- 7.3.4.2. Financial Performance
- 7.3.4.3. Solutions Benchmarking
- 7.3.4.4. Strategic Initiatives
- 7.3.5. VetCT
- 7.3.5.1. Company Overview
- 7.3.5.2. Financial Performance
- 7.3.5.3. Solutions Benchmarking
- 7.3.5.4. Strategic Initiatives
- 7.3.6. Vetology LLC
- 7.3.6.1. Company Overview
- 7.3.6.2. Financial Performance
- 7.3.6.3. Solutions Benchmarking
- 7.3.6.4. Strategic Initiatives
- 7.3.7. OneCup AI
- 7.3.7.1. Company Overview
- 7.3.7.2. Financial Performance
- 7.3.7.3. Solutions Benchmarking
- 7.3.7.4. Strategic Initiatives
- 7.3.8. Petriage
- 7.3.8.1. Company Overview
- 7.3.8.2. Financial Performance
- 7.3.8.3. Solutions Benchmarking
- 7.3.8.4. Strategic Initiatives
- 7.3.9. ImpriMed, Inc.
- 7.3.9.1. Company Overview
- 7.3.9.2. Financial Performance
- 7.3.9.3. Solutions Benchmarking
- 7.3.9.4. Strategic Initiatives
- 7.3.10. IDEXX Laboratories, Inc.
- 7.3.10.1. Company Overview
- 7.3.10.2. Financial Performance
- 7.3.10.3. Solutions Benchmarking
- 7.3.10.4. Strategic Initiatives
- 7.4. List of Other Key Market Players